Thomas Middour, MD
Clinical Cardiac Electrophysiology · Lawrenceville, GANPI 1841618311
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.5%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 43.5% of the total. Reporting peaked in 2021 at $10,697 and has fallen 72.5% since, to $2,937 in 2025.
Across 288 payments — averaging $86.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Abbott$7K
- Boston Scientific$2K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$948
- Medical Device Business Services, Inc.$917
- plus $2K from 18 others
What the payments were for
- Grants$10,00040%
- Travel & lodging$3,96916%
- Food & beverage$10,87343%
- Education$1581%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $10,887 |
| Abbott | 128 | $6,566 |
| Boston Scientific | 44 | $2,023 |
| Biotronik Inc. | 5 | $1,654 |
| Biosense Webster, Inc. | 40 | $948 |
| Medical Device Business Services, Inc. | 4 | $917 |
| Cardiva Medical, Inc. | 9 | $343 |
| AstraZeneca | 12 | $323 |
| Angiodynamics, Inc. | 2 | $177 |
| Amgen | 5 | $173 |
| Atricure, Inc. | 1 | $167 |
| Cvrx, Inc. | 6 | $130 |
| Lantheus Medical Imaging, Inc. | 1 | $124 |
| Pfizer | 2 | $110 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $108 |
| Merck | 4 | $81 |
| Abiomed | 3 | $59 |
| Innovation Technologies Inc | 2 | $46 |
| Heartflow, Inc. | 2 | $40 |
| Johnson & Johnson | 2 | $38 |
| Novartis | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Edwards Lifesciences | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$1,247
- Ensite Cardiac Mapping System$1,038
- Carto 3$1,008
- AVEIR$877
- Farapulse$328
- ENSITE$326
- AFFERA MAPPING SYSTEM$191
- Micra$169
- Merlin Connectivity and Remote$168
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$167
- Advisa$158
- QUADRA ASSURA$146
- Confirm Rx$142
- WATCHMAN Access System$140
- GALLANT$138
- S ICD$137
- Assurity Pacemaker$134
- CDS broad portfolio offering$130
- AlphaVac$130
- Edora 8 DR-T$127
How this compares
$25,000 in reported general payments places this provider in the 55th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 120 | $112,892 |
| XareltoRivaroxaban | 40 | $34,049 |
| Flecainide Acetate | 69 | $1,690 |
| Amiodarone Hcl | 53 | $1,670 |
| Bumetanide | 35 | $1,293 |
| Metoprolol Succinate | 113 | $1,130 |
| Carvedilol | 59 | $475 |
| Potassium Chloride | 30 | $455 |
| Losartan Potassium | 49 | $330 |
| Amlodipine Besylate | 65 | $317 |
| Pantoprazole Sodium | 32 | $299 |
| Atorvastatin Calcium | 40 | $246 |
| SotalolSotalol Hcl | 21 | $216 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 13 | $201 |
| ClopidogrelClopidogrel Bisulfate | 18 | $158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $110 | $112,892120 claims |
| Johnson & JohnsonXarelto | $38 | $34,04940 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Lawrenceville
- Niraj SharmaLawrenceville$61K
- Yasser RodriguezLawrenceville$37K
- David WilsonLawrenceville$13K
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.